Pyruvate kinase (PK) deficiency is a systemic and progressive disease characterized by lifelong chronic hemolysis.1,2
Confirm or rule out PK deficiency today to help prevent serious long-term complications, like iron overload.2,3
SEE THE RISKSPyruvate kinase (PK) deficiency is a systemic and progressive disease characterized by lifelong chronic hemolysis.1,2
Confirm or rule out PK deficiency today to help prevent serious long-term complications, like iron overload.2,3
See the RisksSee the markers of chronic hemolysis that could lead to a PK deficiency diagnosis
GO TO DIAGNOSTIC PATHWAYAnemia ID® is a no-cost genetic testing and counseling program for your Coombs-negative hemolytic anemia patients when hemoglobinopathies have been ruled out
EXPLORE TESTING RESOURCESWatch PK deficiency experts discuss details about their experiences with the disease
HEAR FROM YOUR PEERSAnemia ID® is only available to residents of the United States.
All testing provided to patients through Anemia ID is paid for by Agios Pharmaceuticals. While Agios provides financial support for this program, all tests and services are performed by Revvity Omics or InformedDNA. Agios receives contact information for healthcare professionals who submit tests under this program and limited de-identified aggregate data.
Anemia ID is sponsored by Agios in partnership with Revvity Omics. Other laboratories may also offer genetic testing.
All genetic counseling services provided to patients through Anemia ID are paid for by Agios Pharmaceuticals. While Agios provides financial support for this program, all genetic counseling services are performed by InformedDNA. Agios receives contact information for healthcare professionals who request genetic counseling for their patients under this program and limited de-identified data.
References: 1. Grace RF, Zanella A, Neufeld EJ, et al. Erythrocyte pyruvate kinase deficiency: 2015 status report. Am J Hematol. 2015;90(9):825-830. 2. Zanella A, Fermo E, Bianchi P, Valentini G. Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br J Haematol. 2005;130(1):11-25. 3. Boscoe AN, Yan Y, Hedgeman E, et al. Comorbidities and complications in adults with pyruvate kinase deficiency. Poster presented at: The American Society of Hematology (ASH) Annual Meeting; December 7–10, 2019; Orlando, FL.